Age Matters: How Young and Old Mice Respond Differently to the Same Infection
2026-01-16 16:09
When scientists at a U.S. research institution set out to understand how aging affects the body’s response to infection, they turned to a classic model: sepsis in mice. They exposed both young (12-week-old) and old (75-week-old) mice – roughly equivalent to humans in their 20s and late 60s – to a standardized lethal dose (LD50) of either Escherichia coli or Staphylococcus aureus. The bacterial load was identical across groups, yet outcomes diverged dramatically based on age.
Surprisingly, pre-infection health offered no clue about who would survive. Instead, within just 6 to 10 hours post-infection, clinical signs clearly predicted survival – but not because of differences in pathogen control. Rather, it was the host’s ability to tolerate the infection, not eliminate it, that determined fate.
Divergent Paths to Death
Among mice that ultimately died, both young and old showed signs of systemic collapse – hypothermia, poor circulation – but the underlying damage to organs followed strikingly different patterns.
In young mice, the heart bore the brunt: it became enlarged, swollen, and infiltrated with immune cells. Gene expression profiles pointed to muscle stretch responses, apoptosis, and tissue remodeling gone awry. Levels of BNP – a biomarker for heart failure – were markedly elevated.
In contrast, elderly mice exhibited cardiac atrophy, not enlargement. Their hearts showed signs of cellular self-digestion (autophagy) and increased activity in genes linked to ubiquitination, growth suppression, and impaired cell proliferation. Liver and kidney damage were also more severe in this group.
These findings underscore a key insight: genetically identical hosts, facing the same microbial threat, can succumb through entirely distinct biological pathways shaped by age.
Survival Strategies Shift with Age
The story took another turn among survivors. Young mice that recovered showed virtually no clinical signs of illness – no fever, no hypothermia, no organ dysfunction. Their hearts remained unscathed.
Older survivors, however, did show transient symptoms, which plateaued within 6 – 8 hours and resolved fully by 48 hours. Even when liver stress occurred, it was milder than in non-survivors. Crucially, in both age groups, the heart appeared protected – but through different molecular mechanisms.
Foxo1 and Trim63
At the heart of this age-dependent response lies a pair of genes: Foxo1 and its downstream target Trim63. In healthy mice, cardiac expression of Foxo1 was similar across ages. But during infection, a stark contrast emerged.
In young survivors, Foxo1 and Trim63 were highly upregulated – acting as key mediators of disease tolerance. When researchers blocked Foxo1, young mice became far more vulnerable, confirming its protective role.
Yet in older mice, the same genes played a sinister part. Elevated Foxo1 and Trim63 correlated with organ damage and death. Inhibiting them, conversely, improved survival – suggesting that what shields the young may harm the old.
This duality exemplifies a broader biological principle: mechanisms beneficial in youth can become maladaptive with age. A robust immune or stress response that once ensured survival may later fuel chronic inflammation or tissue breakdown.
Rethinking Treatment Through an Age Lens
Conventional therapies often aim to suppress harmful host responses. But this study delivers a cautionary message: a drug that rescues young mice might endanger older ones and vice versa.
The implication is clear: one-size-fits-all approaches to sepsis (and likely other inflammatory conditions) may be outdated. Instead, treatments should be tailored not only to the pathogen but to the patient’s biological age.
As the global population ages, such precision becomes clinically essential. Understanding how resilience mechanisms evolve over a lifetime could pave the way for smarter, safer interventions that respect the body’s changing priorities across the lifespan.
Publication date: 2026.01.16
Source: Sanchez K.K. et al. Disease tolerance and infection pathogenesis age-related tradeoffs in mice. Nature. 2026 Jan 14. doi: 10.1038/s41586-025-09923-x. Epub ahead of print. PMID: 41535469. https://www.nature.com/articles/s41586-025-09923-x